Evidence map›Paper›PMID 32374757›Full record

ArticlePloS one2020

Presence of HPV with overexpression of p16INK4a protein and EBV infection in penile cancer-A series of cases from Brazil Amazon.

Valquíria do Carmo Alves Martins, Isabela Werneck Cunha, Giuseppe Figliuolo, Heidy Halanna de Melo Farah Rondon, Paloma Menezes de Souza, Felipe Luz Torres Silva, Guilherme Luz Torres Silva, Michele de Souza Bastos, Daniel Barros de Castro, Monique Freire Santana and 3 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Human papillomavirus (HPV) and Epstein-Barr virus (EBV) in Penile Cancer in Thailand.Asian Pacific journal of cancer prevention : APJCP · 2024
    Article
  3. Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 6 institutions in 1 country.

Valquíria do Carmo Alves MartinsDepartment of Education and Research, Fundação Centro de Controle de Oncologia do Estado do Amazonas, Manaus, Amazonas, Brazil.ORCID 0000-0003-1259-9738
Isabela Werneck CunhaDepartment of Pathology, AC Camargo Cancer Center, São Paulo, Brazil.
Giuseppe FigliuoloDepartment of Education and Research, Fundação Centro de Controle de Oncologia do Estado do Amazonas, Manaus, Amazonas, Brazil.
Heidy Halanna de Melo Farah RondonUniversidade Federal do Amazonas, Manaus, Amazonas, Brazil.
Paloma Menezes de SouzaUniversidade do Estado do Amazonas, Manaus, Amazonas, Brazil.
Felipe Luz Torres SilvaUniversidade Federal do Amazonas, Manaus, Amazonas, Brazil.
Guilherme Luz Torres SilvaUniversidade do Estado do Amazonas, Manaus, Amazonas, Brazil.
Michele de Souza BastosDepartment of Virology, Fundação de Medicina Tropical Heitor Vieira Dourado, Manaus, Amazonas, Brazil.
Daniel Barros de CastroGenomic Health Surveillance Network: Optimization of Assistance and Research in The State of Amazonas - REGESAM, Manaus, Amazonas, Brazil.ORCID 0000-0001-5969-544X
Monique Freire SantanaDepartment of Education and Research, Fundação Centro de Controle de Oncologia do Estado do Amazonas, Manaus, Amazonas, Brazil.
Rajendranath RamasawmyGenomic Health Surveillance Network: Optimization of Assistance and Research in The State of Amazonas - REGESAM, Manaus, Amazonas, Brazil.
José Eduardo LeviInstituto de Medicina Tropical, Universidade de São Paulo, São Paulo, Brazil.
Kátia Luz TorresDepartment of Education and Research, Fundação Centro de Controle de Oncologia do Estado do Amazonas, Manaus, Amazonas, Brazil.ORCID 0000-0003-0922-5866
Fundação de Medicina Tropical · BRFundação de Amparo à Pesquisa do Estado do Amazonas · BRUniversidade do Estado do Amazonas · BRUniversidade Federal do Amazonas · BRAC Camargo Hospital · BRUniversidade de São Paulo · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIn Brazil, penile cancer (PC) is not uncommon. The highest incidence of PC is in the North and Northeast of the country. In addition to phimosis, the Human Papillomavirus (HPV) and Epstein-Baar Virus (EBV) infections are also related as risk factors for PC. The overexpression of p16INK4a is a surrogate sensitive marker of HPV infection in PC.

objectivesTo correlate p16INK4a overexpression and HPV infection status with EBV infection in a series of PC patients from the Amazon region.

methodsTumor tissues from 47 PC cases were analyzed for the presence of HPV and EBV DNA by PCR. All PC patients were diagnosed between 2013 and 2018 at a public reference cancer center hospital in Manaus, Amazonas-Brazil. HPV was genotyped using E7 HPV16/HPV18 type-specific real-time PCR and the PapilloCheck® HPV-Screening assay. p16INK4a expression was evaluated by immunohistochemistry using the automated Ventana® BenchMark Ultra.

resultsThe mean age of patients at the time of diagnosis was 57.4 years ±SD 17.8 ranging from 20 to 90 years old. Most of the patients (64%) came from rural areas of the Amazonas State. Thirty patients had phimosis (64%). Among the patients with phimosis, 43% (13/30) underwent circumcision, three during childhood and 10 in adulthood. 60% of the patients were smokers or ex-smokers. HPV infection was observed in 45% (21/47) of cases. HPV16 was detected in 13 patients (61%). Other HPV types detected were HPV 6, 11, 42, 51, 53, 68 and 44/55. EBV infection was observed in 30% (14/47) of the patients with PC. Co-infection with HPV and EBV was observed in 28% (6/21) cases. p16INK4a was only investigated in 26 samples. The p16INK4a overexpression was observed exclusively in HPV 16 positive cases and four HPV negative cases. In the survival analysis, the follow-up time was 35.4 months/patient. The mortality rate during the follow up time was 38%.

conclusionsp16INK4a positivity presented a high correlation to HPV 16 DNA detection, reinforcing its use as a surrogate marker for HPV-driven cancers. Infection with EBV was quite frequent and its role in epithelial penile oncogenesis needs to be demonstrated.

Indexed as

PapillomaviridaeAdultAgedAged, 80 and overBrazilCyclin-Dependent Kinase Inhibitor p16DNA, ViralEpstein-Barr Virus InfectionsGenetic MarkersHerpesvirus 4, HumanHuman papillomavirus 16Human papillomavirus 18HumansKaplan-Meier EstimateMaleMiddle AgedCDKN2A protein, humanCyclin-Dependent Kinase Inhibitor p16DNA, ViralGenetic Markers

Identifiers

PMID32374757
PMCPMC7202603
OpenAlexW3022176582

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.